Tag Archives: Dupilumab Eosinophilic Esophagitis
Dupilumab (Dupixent): The First-Ever FDA Approved Treatment for Eosinophilic Esophagitis
On May 20, 2022, the US Food and Drug Administration (FDA) approved dupilumab (Dupixent) to treat eosinophilic esophagitis (EoE) in […]
